Evidence map›Paper›PMID 35520704›Full record

ArticleRSC advances2019

Novel mono-lipidated dimeric glucagon-like peptide-1 receptor agonist with improved long-acting and hypoglycemic activity.

Lidan Sun, Jing Han, Xinyu Chen, Yue Han, Lingling Wu, Xia E

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lidan SunIntegrated Medicine Research Center for Neurological Rehabilitation, College of Medicine, Jiaxing University Jiaxing 314001 PR China.ORCID https://orcid.org/0000-0002-3869-105X
Jing HanSchool of Chemistry and Chemical Engineering, Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials, Jiangsu Normal University Xuzhou 221116 PR China slidan89@mail.zjxu.edu.cn.ORCID https://orcid.org/0000-0001-5605-1868
Xinyu ChenSchool of Chemistry and Chemical Engineering, Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials, Jiangsu Normal University Xuzhou 221116 PR China slidan89@mail.zjxu.edu.cn.
Yue HanSchool of Chemistry and Chemical Engineering, Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials, Jiangsu Normal University Xuzhou 221116 PR China slidan89@mail.zjxu.edu.cn.
Lingling WuIntegrated Medicine Research Center for Neurological Rehabilitation, College of Medicine, Jiaxing University Jiaxing 314001 PR China.
Xia EIntegrated Medicine Research Center for Neurological Rehabilitation, College of Medicine, Jiaxing University Jiaxing 314001 PR China.
Jiangsu Normal University · CNJiaxing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dimerization is a useful tool to boost ligand-receptor interaction. Both lipidation and dimerization effectively prolong the short half-life (

Identifiers

PMID35520704
PMCPMC9062351
OpenAlexW2924090224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.